SCHEMBL7771

SCHEMBL7771

c1ncc2c[nH]nc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL310497 0.98 EGFR (0.34)
Hydrochloric Acid SCHEMBL311767 0.98 EGFR (0.34)
SCHEMBL3882732 0.89 RPS6KA5 (0.32)
Ether SCHEMBL438449 0.87 PDE5A (0.30)
Acetamide SCHEMBL9934178 0.86 ENPP1 (0.31)
SCHEMBL2350790 0.76 KDM4E (0.44)
Allopurinol SCHEMBL3424531 0.75 XDH (0.61)
SCHEMBL29809882 0.72 EGFR (0.46)
SCHEMBL140301 0.72 EGFR (0.46)
SCHEMBL11024535 0.71 EGFR (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3676 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545682-B2 Heterocyclic derivatives as P2X7 receptor antagonists BREYE THERAPEUTICS APS (DK) 2026-02-10 US claimed
EP-3590516-B1 ANTITUMOR-EFFECT ENHANCER USING PYRAZOLO[3,4-D]PYRIMIDINE COMPOUND TAIHO PHARMACEUTICAL CO LTD (JP) 2025-09-03 EP claimed
EP-4568972-A1 NEW HETEROCYCLIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2025-06-18 EP claimed
WO-2025111482-A1 COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS BEXSON BIOMEDICAL, INC. (US) 2025-05-30 WO claimed
CN-119679800-A Application of 2H-pyrazolo [3,4-d ] pyrimidine derivative in preparation of medicines for preventing, relieving, treating and/or assisting in treating non-alcoholic steatohepatitis 天津济坤医药科技有限公司 2025-03-25 CN claimed
CN-119654326-A Novel heterocyclic compounds 豪夫迈·罗氏有限公司 2025-03-18 CN claimed
EP-4262975-B1 HETEROCYCLIC DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS BREYE THERAPEUTICS APS (DK) 2025-03-05 EP claimed
US-12186320-B2 Therapeutic agent containing pyrazolo[3,4-d]pyrimidine compound as active ingredient TAIHO PHARMACEUTICAL CO., LTD. (JP) 2025-01-07 US claimed
EP-3845231-B1 THERAPEUTIC AGENT CONTAINING PYRAZOLO[3,4-D]PYRIMIDINE COMPOUND AS ACTIVE INGREDIENT TAIHO PHARMACEUTICAL CO LTD (JP) 2025-01-01 EP claimed
WO-2024033277-A1 NEW HETEROCYCLIC COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2024-02-15 WO claimed
EP-0496617-A1 Adenosine kinase inhibitors GENSIA, INC. (US) 1992-07-29 EP claimed
WO-1992003577-A1 OLIGO(ALPHA-ARABINOFURANOSYL NUCLEOTIDES) AND ALPHA-ARABINOFURANOSYL PRECURSORS THEREOF MICROPROBE CORPORATION (US) 1992-03-05 WO claimed
WO-1990003370-A1 DERIVATIVES OF PYRAZOLO[3,4-d]PYRIMIDINE MICROPROBE CORPORATION (US) 1990-04-05 WO claimed
US-4904666-A Pyrazolo(3,4-d)pyrimidine compounds, compositions and method of use BOEHRINGER MANNHEIM GMBH (DE) 1990-02-27 US claimed
US-4511557-A CALF'S BLOOD DIAYSATE AS VASODILATION POTENTIATOR GAURI KAILASH KUMAR (DE) 1985-04-16 US claimed
EP-0106309-A2 Biologically active extracts, process for their manufacture, medicinal and cosmetical preparations comprising them, and their use as additives in foodstuffs and stimulants Gauri, Kailash Kumar, Dr. Prof. (DE) 1984-04-25 EP claimed
EP-0077372-A1 NEW DERIVATIVES OF PYRAZOLO(3,4-d)PYRIMIDINE, PREPARATION METHOD THEREOF AND REMEDY CONTAINING THEM Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1983-04-27 EP claimed
WO-1982003626-A1 NEW DERIVATIVES OF PYRAZOLO(3,4-D)PYRIMIDINE,PREPARATION METHOD THEREOF AND REMEDY CONTAINING THEM GAURI KAILASH KUMAR 1982-10-28 WO claimed
EP-0063381-A1 Pyrazolo(3-4-d) pyrimidines, process for their preparation and pharmaceutical compositions containing them Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1982-10-27 EP claimed
US-4001230-A ANTIBACTERIAL, ANTIPROTAZOAL ELI LILLY AND COMPANY (US) 1977-01-04 US claimed